Your browser doesn't support javascript.
loading
Foxp3 is a key downstream regulator of p53-mediated cellular senescence.
Kim, J-E; Shin, J-S; Moon, J-H; Hong, S-W; Jung, D-J; Kim, J H; Hwang, I-Y; Shin, Y J; Gong, E-Y; Lee, D H; Kim, S-M; Lee, E Y; Kim, Y S; Kim, D; Hur, D; Kim, T W; Kim, K-P; Jin, D-H; Lee, W-J.
Afiliación
  • Kim JE; Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Shin JS; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Moon JH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Hong SW; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Jung DJ; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Kim JH; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Hwang IY; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Shin YJ; Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Gong EY; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Lee DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Kim SM; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Lee EY; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Kim YS; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Kim D; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Hur D; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Kim TW; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Kim KP; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
  • Jin DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Lee WJ; Innovative Cancer Research, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
Oncogene ; 36(2): 219-230, 2017 01 12.
Article en En | MEDLINE | ID: mdl-27238838
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Inhibidor p21 de las Quinasas Dependientes de la Ciclina / Factores de Transcripción Forkhead / Fibroblastos Límite: Animals / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Inhibidor p21 de las Quinasas Dependientes de la Ciclina / Factores de Transcripción Forkhead / Fibroblastos Límite: Animals / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido